HIV patients will be given genetically modified stem cells in an attempt to effectively cure them of the infection, the first time this experimental therapy has been tried. Sangamo Biosciences, based in the Bay Area community of Richmond, received approval from federal regulators Tuesday to conduct the clinical trial.
http://ift.tt/18RUMzA
http://ift.tt/18RUMzA
No comments:
Post a Comment